Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney Disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The polycystic kidney diseases (PKD) are a group of genetic disorders causing renal failure and death from infancy to adulthood. Arginine vasopressin (AVP) V2 receptor antagonists inhibit cystogenesis in animal models of cystic kidney diseases, presumably by downregulating cAMP signaling, cell proliferation, and chloride-driven fluid secretion. For confirmation that the protective effect of these drugs is due to antagonism of AVP, PCK (Pkhd1(-/-)) and Brattleboro (AVP(-/-)) rats were crossed to generate rats with PKD and varying amounts of AVP. At 10 and 20 weeks of age, PCK AVP(-/-) rats had lower renal cAMP and almost complete inhibition of cystogenesis compared with PCK AVP(+/+) and PCK AVP(+/-) rats. The V2 receptor agonist 1-deamino-8-d-arginine vasopressin increased renal cAMP and recovered the full cystic phenotype of PCK AVP(-/-) rats and aggravated the cystic disease of PCK AVP(+/+) rats but did not induce cystic changes in wild-type rats. These observations indicate that AVP is a powerful modulator of cystogenesis and provide further support for clinical trials of V2 receptor antagonists in PKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationWard, C. J., Hogan, M. C., Rossetti, S., Walker, D., Sneddon, T., Wang, X., Kubly, V., Cunningham, J. M., Bacallao, R., Ishibashi, M., et al. (2002) · Nature Genetics · doi:10.1038/ng833 · Cited by 765
Self-citationGattone, V. H., Wang, X., Harris, P. C., & Torres, V. E. (2003) · Nature Medicine · doi:10.1038/nm935 · Cited by 670
Self-citationComparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Gabow, P. A., Johnson, A. M., Kaehny, W. D., Kimberling, W. J., Lezotte, D. C., Duley, I. T., & Jones, R. H. (1992) · Kidney International · doi:10.1038/ki.1992.195 · Cited by 509
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
Torres, V. E., Wang, X., Qian, Q., Somlo, S., Harris, P. C., & Gattone, V. H. (2004) · Nature Medicine · doi:10.1038/nm1004 · Cited by 482
Self-citationSingle base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats
Schmale, H., & Richter, D. (1984) · Nature · doi:10.1038/308705a0 · Cited by 401
Wang, X., Gattone, V., Harris, P. C., & Torres, V. E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121090 · Cited by 334
Self-citationMechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases
Torres, V. E., & Harris, P. C. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0070 · Cited by 296
Self-citationHarris, P. C., Bae, K. T., Rossetti, S., Torres, V. E., Grantham, J. J., Chapman, A. B., Guay-Woodford, L. M., King, B. F., Wetzel, L. H., Baumgarten, D. A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080835 · Cited by 271
Self-citationIncreased Water Intake Decreases Progression of Polycystic Kidney Disease in the PCK Rat
Nagao, S., Nishii, K., Katsuyama, M., Kurahashi, H., Marunouchi, T., Takahashi, H., & Wallace, D. P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030251 · Cited by 241
Rossetti, S., Chauveau, D., Kubly, V., Slezak, J. M., Saggar-Malik, A. K., Pei, Y., Ong, A. C., Stewart, F., Watson, M. L., Bergstralh, E. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13773-7 · Cited by 223
Self-citationSelected Contribution: Sex differences in osmotic regulation of AVP and renal sodium handling
Stachenfeld, N. S., Splenser, A. E., Calzone, W. L., Taylor, M. P., & Keefe, D. L. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1893 · Cited by 189
The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease
Lager, D. J., Qian, Q., Bengal, R. J., Ishibashi, M., & Torres, V. E. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00473.x · Cited by 186
Self-citationPerucca, J., Bouby, N., Valeix, P., & Bankir, L. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00500.2006 · Cited by 184
Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease
Magistroni, R., He, N., Wang, K., Andrew, R., Johnson, A., Gabow, P., Dicks, E., Parfrey, P., Torra, R., San-Millan, J. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000061774.90975.25 · Cited by 147
Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.
Ouchi, Y., Share, L., Crofton, J. T., IITAKE, K., & Brooks, D. P. (1987) · Hypertension · doi:10.1161/01.hyp.9.2.172 · Cited by 147
Role of vasopressin in essential hypertension
Bakris, G. L., Bursztyn, M., Gavras, I., Bresnahan, M. R., & Gavras, H. P. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715050-00011 · Cited by 105
Selective ADH-induced hypertrophy of the medullary thick ascending limb in Brattleboro rats
Bouby, N., Bankir, L., Trinh‐Trang‐Tan, M., Minuth, W. W., & Kriz, W. (1985) · Kidney International · doi:10.1038/ki.1985.152 · Cited by 79
Contribution of vasopressin to progression of chronic renal failure: Study in Brattleboro rats
Bouby, N., Hassler, C., & Bankir, L. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00330-6 · Cited by 78
Adaptation of the rat kidney to altered water intake and urine concentration
Bankir, L., Fischer, C., Fischer, S., Jukkala, K., Specht, H.-C., Kriz, W., Hähnel, B., Hartmann, I., Ertel, I., & Coutaud, C. (1988) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00583730 · Cited by 76
Seeman, T., Dušek, J., Vondrák, K., Bláhová, K., Šimková, E., Kreisinger, J., Dvořák, P., Kynčl, M., Hříbal, Z., & Janda, J. (2006) · Physiological Research · doi:10.33549/physiolres.930528 · Cited by 69
Vasopressin: Sexual dimorphism in secretion, cardiovascular actions and hypertension
Share, L., Crofton, J. T., & Ouchi, Y. (1988) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198804000-00017 · Cited by 62
Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets
Crofton, J. T., Dustan, H. R., Share, L., & Brooks, D. P. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1080191 · Cited by 45
Sex difference in the antidiuretic activity of vasopressin in the rat
Wang, Y. X., Edwards, R. M., Nambi, P., Stack, E. J., Pullen, M., Share, L., Crofton, J. T., & Brooks, D. P. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.6.r1284 · Cited by 38
Oestrogen effects on urine concentrating response in young women
Stachenfeld, N. S., Taylor, H. S., Leone, C. A., & Keefe, D. L. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.046920 · Cited by 33
Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats
Wang, Y. X., Crofton, J. T., Liu, H., Sato, K., Brooks, D. P., & Share, L. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.268.4.r951 · Cited by 33
Takei, Y., Kawakoshi, A., Tsukada, T., Yuge, S., Ogoshi, M., Inoue, K., Hyodo, S., Bannai, H., & Miyano, S. (2006) · Journal of Experimental Zoology Part A Comparative Experimental Biology · doi:10.1002/jez.a.309 · Cited by 32
Kohl, J., & Koller, E. A. (1988) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00581644 · Cited by 27
HATANO, T., OGAWA, K., KANDA, K., SEO, H., & MATSUI, N. (1988) · Endocrinologia Japonica · doi:10.1507/endocrj1954.35.267 · Cited by 16
Cited by
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Grantham, J. J., Higashihara, E., Perrone, R. D., Krasa, H. B., Ouyang, J., & Czerwiec, F. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205511 · Cited by 1,614
Self-citationAutosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationInsufficient Sleep in Adolescents and Young Adults: An Update on Causes and Consequences
Owens, J., ADOLESCENT SLEEP WORKING GROUP, COMMITTEE ON ADOLESCENCE, Au, R., Carskadon, M., Millman, R., Wolfson, A., Braverman, P. K., Adelman, W. P., Breuner, C. C., et al. (2014) · Pediatrics · doi:10.1542/peds.2014-1696 · Cited by 1,413
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Perrone, R. D., Koch, G., Ouyang, J., McQuade, R. D., Blais, J. D., Czerwiec, F. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1710030 · Cited by 639
Self-citationAutosomal dominant polycystic kidney disease
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32782-x · Cited by 624
Metadata
- Authors
- Wang, X., Wu, Y., Ward, C. J., Harris, P. C., & Torres, V. E.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-01
- Volume
- 19
- Issue
- 1
- Pages
- 102-108
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2130729770
- Cited by
- 286
- References
- 30
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.